Cargando…

High-utilizing Crohn's disease patients under psychosomatic therapy*

OBJECTIVE: Few studies have been published on health care utilization in Crohn's disease and the influence of psychological treatment on high utilizers. METHODS: The present sub study of a prospective multi center investigation conducted in 87 of 488 consecutive Crohn's disease (CD) patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Deter, Hans-Christian, von Wietersheim, Jörn, Jantschek, Günther, Burgdorf, Friederike, Blum, Brigitta, Keller, Wolfram
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579292/
https://www.ncbi.nlm.nih.gov/pubmed/18851749
http://dx.doi.org/10.1186/1751-0759-2-18
_version_ 1782160565355937792
author Deter, Hans-Christian
von Wietersheim, Jörn
Jantschek, Günther
Burgdorf, Friederike
Blum, Brigitta
Keller, Wolfram
author_facet Deter, Hans-Christian
von Wietersheim, Jörn
Jantschek, Günther
Burgdorf, Friederike
Blum, Brigitta
Keller, Wolfram
author_sort Deter, Hans-Christian
collection PubMed
description OBJECTIVE: Few studies have been published on health care utilization in Crohn's disease and the influence of psychological treatment on high utilizers. METHODS: The present sub study of a prospective multi center investigation conducted in 87 of 488 consecutive Crohn's disease (CD) patients was designed to investigate the influence of the course of Crohn's disease on health care utilization (hospital days (HD) and sick leave days (SLD) collected by German insurance companies) and to examine the conditions of high-utilizing patients. Predictors of health care utilization should be selected. Based on a standardized somatic treatment, high health care utilizing patients of the psychotherapy and control groups should be compared before and after a one-year treatment. RESULTS: Multivariate regression analysis identified disease activity at randomization as an important predictor of the clinical course (r(2 )= 0.28, p < 0.01). Health care utilization correlated with duration of disease (p < 0.04), but the model was not significant (r(2 )= 0.15, p = 0.09). The patients' level of anxiety, depression and lack of control at randomization predicted their health-related quality of life at the end of the study (r(2 )= 0.51, p < 0.00001). Interestingly, steroid intake and depression (t1) predicted the combined outcome measure (clinical course, HRQL, health care utilization) of Crohn's disease at the end of the study (r(2 )= 0.22, p < 0.001). Among high utilizers, a significantly greater drop in HD (p < 0.03) and in mean in SLD were found in the treatment compared to the control group. CONCLUSION: The course of Crohn's disease is influenced by psychological as well as somatic factors; especially depression seems important here. A significant drop of health care utilization demonstrates the benefit of psychological treatment in the subgroup of high-utilizing CD patients. Further studies are needed to replicate the findings of the clinical outcome in this CD subgroup.
format Text
id pubmed-2579292
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25792922008-11-05 High-utilizing Crohn's disease patients under psychosomatic therapy* Deter, Hans-Christian von Wietersheim, Jörn Jantschek, Günther Burgdorf, Friederike Blum, Brigitta Keller, Wolfram Biopsychosoc Med Research OBJECTIVE: Few studies have been published on health care utilization in Crohn's disease and the influence of psychological treatment on high utilizers. METHODS: The present sub study of a prospective multi center investigation conducted in 87 of 488 consecutive Crohn's disease (CD) patients was designed to investigate the influence of the course of Crohn's disease on health care utilization (hospital days (HD) and sick leave days (SLD) collected by German insurance companies) and to examine the conditions of high-utilizing patients. Predictors of health care utilization should be selected. Based on a standardized somatic treatment, high health care utilizing patients of the psychotherapy and control groups should be compared before and after a one-year treatment. RESULTS: Multivariate regression analysis identified disease activity at randomization as an important predictor of the clinical course (r(2 )= 0.28, p < 0.01). Health care utilization correlated with duration of disease (p < 0.04), but the model was not significant (r(2 )= 0.15, p = 0.09). The patients' level of anxiety, depression and lack of control at randomization predicted their health-related quality of life at the end of the study (r(2 )= 0.51, p < 0.00001). Interestingly, steroid intake and depression (t1) predicted the combined outcome measure (clinical course, HRQL, health care utilization) of Crohn's disease at the end of the study (r(2 )= 0.22, p < 0.001). Among high utilizers, a significantly greater drop in HD (p < 0.03) and in mean in SLD were found in the treatment compared to the control group. CONCLUSION: The course of Crohn's disease is influenced by psychological as well as somatic factors; especially depression seems important here. A significant drop of health care utilization demonstrates the benefit of psychological treatment in the subgroup of high-utilizing CD patients. Further studies are needed to replicate the findings of the clinical outcome in this CD subgroup. BioMed Central 2008-10-13 /pmc/articles/PMC2579292/ /pubmed/18851749 http://dx.doi.org/10.1186/1751-0759-2-18 Text en Copyright © 2008 Deter et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Deter, Hans-Christian
von Wietersheim, Jörn
Jantschek, Günther
Burgdorf, Friederike
Blum, Brigitta
Keller, Wolfram
High-utilizing Crohn's disease patients under psychosomatic therapy*
title High-utilizing Crohn's disease patients under psychosomatic therapy*
title_full High-utilizing Crohn's disease patients under psychosomatic therapy*
title_fullStr High-utilizing Crohn's disease patients under psychosomatic therapy*
title_full_unstemmed High-utilizing Crohn's disease patients under psychosomatic therapy*
title_short High-utilizing Crohn's disease patients under psychosomatic therapy*
title_sort high-utilizing crohn's disease patients under psychosomatic therapy*
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579292/
https://www.ncbi.nlm.nih.gov/pubmed/18851749
http://dx.doi.org/10.1186/1751-0759-2-18
work_keys_str_mv AT deterhanschristian highutilizingcrohnsdiseasepatientsunderpsychosomatictherapy
AT vonwietersheimjorn highutilizingcrohnsdiseasepatientsunderpsychosomatictherapy
AT jantschekgunther highutilizingcrohnsdiseasepatientsunderpsychosomatictherapy
AT burgdorffriederike highutilizingcrohnsdiseasepatientsunderpsychosomatictherapy
AT blumbrigitta highutilizingcrohnsdiseasepatientsunderpsychosomatictherapy
AT kellerwolfram highutilizingcrohnsdiseasepatientsunderpsychosomatictherapy
AT highutilizingcrohnsdiseasepatientsunderpsychosomatictherapy